Hair Loss Surgery Before And After
~ Entered into Exclusive Global License Agreement with CSL Behring for Development and Commercialization of uniQure’s Gene Therapy Candidate for Hemophilia B ~ LEXINGTON, Mass. and AMSTERDAM, July 30, .
~ Entered into Exclusive Global License Agreement with CSL Behring for Development and Commercialization of uniQure’s Gene Therapy Candidate for Hemophilia B ~ LEXINGTON, Mass. and AMSTERDAM, July 30, .